OmniAb, Inc. SEC filings OABI
OmniAb, Inc. has 387 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 17, 2026 |
| 10-K | Annual report | Mar 4, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 30, 2026 | Jan 30, 2026 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| EFFECT | Filing | Sep 19, 2025 | — |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| S-3 | Shelf registration | Sep 12, 2025 | — |
| D | Filing | Sep 10, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 25, 2025 | Aug 24, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 17, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2025 | Apr 18, 2025 |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| UPLOAD | Letter from the SEC | Sep 27, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 18, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 18, 2024 |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| EFFECT | Filing | Dec 18, 2023 | — |
| EFFECT | Filing | Dec 18, 2023 | — |
| CORRESP | Letter to the SEC | Dec 14, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2023 | — |
| POS AM | Filing | Dec 8, 2023 | — |
| S-3 | Shelf registration | Dec 8, 2023 | — |
| 424B3 | Prospectus | Nov 13, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 424B3 | Prospectus | Nov 2, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2023 | Nov 1, 2023 |
| 424B3 | Prospectus | Aug 10, 2023 | — |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2023 | Jun 23, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| EFFECT | Filing | May 10, 2023 | — |
| POS AM | Filing | May 5, 2023 | — |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 31, 2023 | Mar 31, 2023 |
| POS EX | Filing | Mar 31, 2023 | — |
| 424B3 | Prospectus | Mar 31, 2023 | — |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| EFFECT | Filing | Feb 10, 2023 | — |
| 424B3 | Prospectus | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| S-1/A | Amended registration statement | Feb 7, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2023 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| CORRESP | Letter to the SEC | Jan 5, 2023 | — |
| S-1/A | Amended registration statement | Jan 5, 2023 | — |
| S-8 | Employee stock plan registration | Jan 3, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2022 | — |
| S-1 | Registration statement | Nov 30, 2022 | — |
| 8-K |
Current report
Other events
|
Nov 18, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2022 | Nov 15, 2022 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Nov 14, 2022 | Nov 1, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K/A |
Amended current report
Auditor change, Bylaw or fiscal year change, Other events
|
Nov 7, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change
|
Nov 7, 2022 | Nov 1, 2022 |
| 25-NSE | Delisting notice | Nov 1, 2022 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| 425 | Filing | Oct 3, 2022 | — |
| 425 | Filing | Oct 3, 2022 | — |
| EFFECT | Filing | Sep 30, 2022 | — |
| 424B3 | Prospectus | Sep 30, 2022 | — |
| CORRESP | Letter to the SEC | Sep 28, 2022 | — |
| S-4/A | Filing | Sep 27, 2022 | — |
| CORRESP | Letter to the SEC | Sep 27, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| SEC STAFF LETTER | Filing | Sep 16, 2022 | — |
| S-4/A | Filing | Sep 13, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2022 | — |
| 8-K |
Current report
Listing notice, Officer or director change
|
Aug 25, 2022 | Aug 22, 2022 |
| 425 | Filing | Aug 24, 2022 | — |
| CORRESP | Letter to the SEC | Aug 22, 2022 | — |
| S-4/A | Form s-4/a | Aug 22, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2022 | — |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| S-4/A | Filing | Jul 26, 2022 | — |
| CORRESP | Letter to the SEC | Jul 26, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2022 | — |
| 425 | Filing | Jun 21, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2022 | Jun 21, 2022 |
| S-4/A | Form s-4/a | Jun 13, 2022 | — |
| CORRESP | Letter to the SEC | Jun 10, 2022 | — |
| SEC STAFF LETTER | Filing | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| 10-Q | Quarterly report | May 20, 2022 | Mar 31, 2022 |
| NT 10-Q | Filing | May 16, 2022 | Mar 31, 2022 |
| 425 | Filing | May 5, 2022 | — |
| DEL AM | Filing | Apr 29, 2022 | — |
| S-4 | Registration for a merger or exchange | Apr 28, 2022 | — |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 425 | Filing | Mar 24, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 24, 2022 | Mar 23, 2022 |
| 425 | Filing | Mar 23, 2022 | — |
| 8-K |
Current report
Other events
|
Mar 23, 2022 | Mar 23, 2022 |
| 8-K |
Current report
New debt
|
Mar 14, 2022 | Mar 14, 2022 |
| 8-K/A |
Amended current report
Other events
|
Jan 28, 2022 | Aug 12, 2021 |
| 10-Q/A | Amended quarterly report | Jan 12, 2022 | Sep 30, 2021 |
| 8-K |
Current report
Restatement
|
Dec 1, 2021 | Nov 30, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Sep 27, 2021 | Sep 27, 2021 |
| 10-Q | Quarterly report | Sep 23, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Aug 18, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Other events
|
Aug 12, 2021 | Aug 9, 2021 |
| 424B4 | Prospectus | Aug 11, 2021 | — |
| CERT | Filing | Aug 10, 2021 | — |
| EFFECT | Filing | Aug 9, 2021 | — |
| 8-A12B | Filing | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| S-1/A | Amended registration statement | Jul 28, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| S-1 | Registration statement | Jun 17, 2021 | — |
| DRSLTR | Filing | May 12, 2021 | — |
| DRS/A | Filing | May 12, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2021 | — |
| DRS | Filing | Mar 19, 2021 | — |
Showing 157 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- OABI (Nasdaq), OABIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1846253
- Former names
- Avista Public Acquisition Corp. II (until Nov 1, 2022)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.